Cargando…

Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy

BACKGROUND: Pharmacological doses of corticoids may result in adrenal suppression but with individual sensitivity. In paediatric inflammatory bowel disease (IBD), glucocorticoids are needed in the majority of the patients but there are less studies related to tapering off the drugs. The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sidoroff, Marianne, Kolho, Kaija-Leena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987131/ https://www.ncbi.nlm.nih.gov/pubmed/24661924 http://dx.doi.org/10.1186/1471-230X-14-51

Ejemplares similares

Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease
por: Kolho, Kaija-Leena
Publicado: (2021)

Trends in Early Outpatient Drug Therapy in Pediatric Inflammatory Bowel Disease in Finland: A Nationwide Register-Based Study in 1999–2009
por: Virta, Lauri J., et al.
Publicado: (2012)

Sleep and Emotional and Behavioral Symptoms in Adolescents with Inflammatory Bowel Disease
por: Pirinen, Teija, et al.
Publicado: (2014)

Clustering of pediatric onset inflammatory bowel disease in Finland: a nationwide register-based study
por: Nikkilä, Atte, et al.
Publicado: (2022)

Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis
por: Nousiainen, Pauliina, et al.
Publicado: (2014)

Pre-Diagnostic Saliva Microbiota of School-Aged Children Who Developed Type 1 Diabetes or Inflammatory Bowel Diseases
por: Räisänen, Laura, et al.
Publicado: (2023)

Perinatal risk factors for pediatric onset type 1 diabetes, autoimmune thyroiditis, juvenile idiopathic arthritis, and inflammatory bowel diseases
por: Räisänen, Laura, et al.
Publicado: (2021)

Fecal Calprotectin and Clinical Disease Activity in Pediatric Ulcerative Colitis
por: Kolho, Kaija-Leena, et al.
Publicado: (2013)

Lactose inhibits regulatory T-cell-mediated suppression of effector T-cell interferon-γ and IL-17 production
por: Paasela, Monika, et al.
Publicado: (2014)

Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel Disease
por: Höyhtyä, Miikka, et al.
Publicado: (2022)

The gut fungal and bacterial microbiota in pediatric patients with inflammatory bowel disease introduced to treatment with anti-tumor necrosis factor-α
por: Ventin-Holmberg, Rebecka, et al.
Publicado: (2022)

Central obesity in school‐aged children increases the likelihood of developing paediatric autoimmune diseases
por: Räisänen, Laura, et al.
Publicado: (2021)

Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases
por: Räisänen, Laura, et al.
Publicado: (2023)

Fecal microbiota in congenital chloride diarrhea and inflammatory bowel disease
por: Wedenoja, Satu, et al.
Publicado: (2022)

Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use
por: Aalto, Kristiina, et al.
Publicado: (2017)

Growth of children with biliary atresia living with native livers: impact of corticoid therapy after portoenterostomy
por: Ruuska, Satu Maria, et al.
Publicado: (2018)

Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice
por: Bruscoli, Stefano, et al.
Publicado: (2021)

Adrenal suppression from glucocorticoids: preventing an iatrogenic cause of morbidity and mortality in children
por: Ahmet, Alexandra, et al.
Publicado: (2019)

Adrenal suppression in patients with chronic obstructive pulmonary disease treated with glucocorticoids: Role of specific glucocorticoid receptor polymorphisms
por: Sivapalan, Pradeesh, et al.
Publicado: (2022)

The clinical course after glucocorticoid treatment in patients with inflammatory bowel disease is linked to suppression of the hypothalamic–pituitary–adrenal axis: a retrospective observational study
por: Ibrahim, Aghil, et al.
Publicado: (2017)

Duration of Suppression of Adrenal Steroids after Glucocorticoid Administration
por: Fuqua, John S., et al.
Publicado: (2010)

Extra-adrenal glucocorticoid biosynthesis: Implications for autoimmune and inflammatory disorders.
por: Slominski, Radomir, et al.
Publicado: (2020)

Clinical indicators of adrenal insufficiency following discontinuation of oral glucocorticoid therapy: A Danish population-based self-controlled case series analysis
por: Laugesen, Kristina, et al.
Publicado: (2019)

Sex- and weight-specific changes in the frequency of sweet treat consumption during early adolescence: a longitudinal study
por: Lommi, Sohvi, et al.
Publicado: (2021)

Evidence-Based Approach to the Discontinuation of Immunomodulators or Biologics in Inflammatory Bowel Disease
por: Miyatani, Yusuke, et al.
Publicado: (2023)

The Composition and Functional Capacities of Saliva Microbiota Differ Between Children With Low and High Sweet Treat Consumption
por: Lommi, Sohvi, et al.
Publicado: (2022)

Early discontinuation of biological therapy among inflammatory bowel disease patients in Bahrain: Real world experience
por: Abdulla, Maheeba, et al.
Publicado: (2022)

Apparent Hypothalamic-Pituitary-Adrenal Axis Suppression via Reduction of Interleukin-6 by Glucocorticoid Therapy in Systemic Autoimmune Diseases
por: Fujio, Natsuki, et al.
Publicado: (2016)

Antibiotic exposures and the development of pediatric autoimmune diseases: a register-based case–control study
por: Räisänen, Laura K., et al.
Publicado: (2022)

Disease control and psychiatric comorbidity among adolescents with chronic medical conditions: a single-centre retrospective study
por: Kallio, Mira, et al.
Publicado: (2023)

Glucocorticoid and dietary effects on mucosal microbiota in canine inflammatory bowel disease
por: Atherly, Todd, et al.
Publicado: (2019)

NGS study of glucocorticoid response genes in inflammatory bowel disease patients
por: Skrzypczak-Zielinska, Marzena, et al.
Publicado: (2019)

Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease
por: Heier, Christopher R, et al.
Publicado: (2016)

Screening for Anxiety and Depression in Children with Congenital Adrenal Hyperplasia
por: Jacob, Marianne, et al.
Publicado: (2023)

Dexamethasone Therapy of Congenital Adrenal Hyperplasia and the Myth of the “Growth Toxic” Glucocorticoid
por: Rivkees, Scott A.
Publicado: (2010)

Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review
por: Joseph, Rebecca M., et al.
Publicado: (2016)

Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency
por: Oprea, Alina, et al.
Publicado: (2019)

Glucocorticoid replacement therapy for primary and secondary adrenal insufficiency and their impact on cognition
por: Harbeck, Birgit, et al.
Publicado: (2023)

Recovery of Adrenal Function in Patients with Glucocorticoids Induced Secondary Adrenal Insufficiency
por: Baek, Jong Ha, et al.
Publicado: (2016)

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
por: Park, Jihye, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_edt11qo3iphd56hct7plorkf6f